The AANS/CNS Drugs and Devices Committee is actively engaged with the Food and Drug Administration (FDA) and other scientific, governmental, clinical and industry representatives to provide neurosurgical expertise on drugs, devices and biologics used to treat patients and to foster innovation and patient safety. These activities include recommending neurosurgeon experts to serve on the FDA Advisory panels, providing input on FDA Guidance Documents and testimony at panel meetings, as appropriate. In addition, organized neurosurgery is an official partner with the FDA's Network of Experts program to provide rapid clinical assistance to FDA reviewers. The AANS and CNS continue to advocate policies that will decrease the regulatory burden for medical-device innovation and ensure patient access to new and improved medical technology.
Letters
Dear Acting Commissioner Ostroff, We are writing to express support for addressing barriers to communication that exist betweenphysicians and drug and device manufacturers. To enhance patient care, physicians must haveunrestricted […]
Letters
Subject: H.R. 160, the Protect Medical Innovation Act Dear Speaker Boehner and Leader Pelosi, On behalf of the American Association of Neurological Surgeons (AANS) and the Congress of NeurologicalSurgeons (CNS), […]
Article
House Ways and Means Committee Takes Important Step to Further Medical Innovation Neurosurgeons Applaud the Committee for Approving Legislation to Repeal the Medical Device Tax Washington, DC – The American […]
Letters
The Honorable Michael C. Burgess, MDUnited States House of Representatives2336 Rayburn House Office BuildingWashington, DC 20515 Dear Dr. Burgess: The undersigned physician organizations representing both national specialty medical societies and […]
Article
Published: April 23, 2015
Senate Finance Health Subcommittee Holds Critical Hearing on Medical Device TaxNeurosurgeons Urge Congress to Repeal the Device Tax Washington, DC – The American Association of Neurological Surgeons (AANS) and Congress […]
Letters
Published: February 19, 2015
Re: American Medical Association, Harm Reduction Coalition and National Safety Council urgeincreased focus on overdose prevention and treatment Dear Dr. Crippen On behalf of the nation’s physicians and medical students, […]
Letters
Published: September 2, 2014
Re: Medicare Program; Revisions to Payment Policies under the Physician FeeSchedule, Clinical Laboratory Fee Schedule & Other Revisions to Part B for CY2015; CMS-1612-P Dear Ms. Tavenner: On behalf of […]
Letters
Re: Open Payments Program: Registration Processes / Review, Dispute and Correction ofPublic Data Dear Administrator Tavenner: On behalf of the Alliance of Specialty Medicine (the Alliance) and its member organizations, […]
Letters
Dear Administrator Tavenner: We, the undersigned organizations, write to identify certain pressing issues related toimplementation of the Physician Payments Sunshine Act (Sunshine Act). As representatives ofmultiple physician organizations and manufacturers […]
Letters
Re: Agency Information Collection Activities: Submission for OMB Review; CommentRequest [Document Identifier: CMS–10495] Dear Ms. Tavenner: On behalf of the American Association of Neurological Surgeons (AANS) and the Congress ofNeurological […]
Letters
Re: Revised Draft Guidance for Industry: Distributing Scientific and Medical Publications onUnapproved New Uses – Recommended Practices Dear Assistant Commissioner Kux: The Alliance of Specialty Medicine (Alliance) is a coalition […]
Article
Physician-Directed Applications A Position Statement of the Alliance of Specialty Medicine Physician-Directed Applications Physician-directed applications, also known as “off-label” 1 uses, are an integralcomponent of the art and science of […]
Letters
Published: February 13, 2013
RE: Consideration of Neurostimulation for Epilepsy, FDA Neurological Devices Panel Meeting,February 22, 2013 Dear Dr. Krauthamer: The American Association of Neurological Surgeons (AANS) and the Congress of NeurologicalSurgeons (CNS) appreciate […]
Letters
Published: February 8, 2013
RE: Support of S. 236, the “Medicare Patient Empowerment Act” Dear Senator Murkowski: As the Alliance of Specialty Medicine (Alliance), our mission is to advocate for soundfederal health care policy […]
Article
Published: January 1, 2013
REFORMING THE REFORM ABOLISH THE INDEPENDENT PAYMENT ADVISORY BOARD (IPAB)Established by the Patient Protection and Affordable Care Act (ACA), the IPAB is a 15-member government board whosemembers are appointed by […]
Letters
Published: August 28, 2012
RE: Classification of posterior cervical screws, including pedicle and lateralmass screws [Docket No. FDA–2012–N–0001] FDA Orthopaedic andRehabilitation Devices Panel of the Medical Devices Advisory Committee Dear Ms. Anderson: The American […]
